Fundz

OncoNano Medicine and Gilead Sciences Enter Research Collaboration for ON-BOARD™ Technology on Gilead’s Drug Candidate.

Jan 06, 2026

Contract Type

partnership

DallasBiotechnologyHealth CareMedicalTherapeutics

Description

OncoNano Medicine has announced a research collaboration with Gilead Sciences to evaluate the effectiveness of its ON-BOARD™ delivery technology with Gilead's drug candidate. The agreement includes opportunities for milestone payments and royalties based on the success of the collaboration.

Company Information

Company

OncoNano Medicine

Location

3060 Pegasus Park Drive

Dallas, Texas, United States

About

OncoNano is harnessing the power of nanotechnology to unlock a new era of targeted therapeutics. Our ON-BOARD™ polymeric micelle platform exploits the highly acidic tumor microenvironment, a byproduct of cancer metabolism, to precisely deliver therapeutic payloads directly to the tumor site. OncoNano’s product candidates are designed to improve the pharmacokinetic and pharmacodynamic properties of various payloads from small molecules to large biologics through encapsulation and localized tumor targeting.

Related People

Matthew
Likely contact at this company
••••••••@••••••••

See Matthew's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for OncoNano Medicine's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

OncoNano Medicine signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.